Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis

Clinical Toxicology

Volumn 50, Issue 10, 2012, Pages 1165-1168

  Thornton, Stephen L ^a   Lo, Jean ^b   Clark, Richard F ^c   Wu, Alan H B ^d   Gerona, Roy R ^d  

^a UNIVERSITY OF KANSAS   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Cannabicyclohexanol; JWH 072; MDPPP

Indexed keywords

3',4' METHYLENEDIOXY ALPHA PYRROLIDINOPROPIOPHENONE; 3,4 METHYLENEDIOXYAMPHETAMINE; AMMONIA; CANNABICYCLOHEXANOL; CANNABINOID 2 RECEPTOR AGONIST; CHLORPROMAZINE; DESIGNER DRUG; DIAZEPAM; DIPHENHYDRAMINE; DROPERIDOL; HALOPERIDOL; JWH 072; LITHIUM; LORAZEPAM; NATURAL PRODUCT; OLANZAPINE; PHENETHYLAMINE; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; AGITATION; ATAXIA; AUDITORY HALLUCINATION; BEHAVIOR DISORDER; CASE REPORT; CEREBROSPINAL FLUID; CHRONIC DISEASE; DISEASE DURATION; DRUG BLOOD LEVEL; EMERGENCY WARD; FOLLOW UP; HUMAN; LUMBAR PUNCTURE; MYDRIASIS; PARANOIA; PSYCHOSIS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SERUM; SIDE EFFECT; SOMNOLENCE; SUBSTANCE ABUSE; URINE;

ADOLESCENT; CANNABINOIDS; CYCLOHEXANOLS; DESIGNER DRUGS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PHENOLS; PIPERIDINES; PSYCHOSES, SUBSTANCE-INDUCED; SUBSTANCE ABUSE DETECTION;

EID: 84871875299     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2012.744996     Document Type: Review

References (15)

1. Z awilska J B. "Legal highs" - new players in the old drama. C urr Drug Abuse Rev 2011; 4: 122-130.
2. Atwood BK, Lee D, Straiker A, Widlanski TS, Mackie K. CP47,497- C8 and JWH073, commonly found in ' Spice ' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists. Eur J Pharmacol 2011; 659: 139-145.
3. Huffman JW, Zengin G, Wu MJ, Lu J, Hynd G, Bushell K, et al. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoylsubstituents. New highly selective CB(2) receptor agonists. Bioorg Med Chem 2005; 13: 89-112.
4. Anand P, Whiteside G, Fowler CJ, Hohmann AG. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev 2009; 60: 25566.
5. Ishiguro H, Horiuchi Y, I shikawa M, K oga M, I mai K, S uzuki Y, et a l. Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry 2010; 67: 974-982. Epub 200. Nov 22.
6. O rtega-Alvaro A, A racil-Ferna n dez A, G arci a -Gutie r rez M S, Navarrete F, Manzanares J. Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology 2011; 36: 1489-1504. Epub 201. Mar 23.
7. Huestis MA, Boyd SJ, Heishman SJ, Preston KL, Bonnet D, Le Fur G, Gorelick DA. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl) 2007; 194: 505-515.
8. Hurst D, Loeffler G, McLay R. Psychosis associated with synthetic cannabinoids agonists: a case series. Am J Psychiatry 2011; 168: 1119.
9. Meltzer P C, Butler D, Deschamps J R, Madras B K. 1 -(4-Methylphenyl)- 2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 2006; 49: 1420-1432.
10. Spiller HA, Ryan ML, Weston RG, Jansen J. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011; 49: 499-505.
11. Smollin C, Murray S, Gerona R. An unexpected finding of MDPPP in a patient with severe agitation and hallucinations. [Abstract]. Clin Toxicol 2011; 49: 515-627.
12. Libiseller K, Pavlic M, Grubwieser P, Rabl W. An announced suicide with ecstasy. Int J Legal Med 2007; 121: 40-43.
13. Van der Veer N, Friday J. Persistent psychosis following the use of Spice. Schizophr Res 2011; 130: 285-286.
14. Vaiva G, Boss V, Bailly D, Thomas P, Lestavel P, Goudemand M. An "accidental" acute psychosis with ecstasy use. J Psychoactive Drugs. 2001; 33: 95-98.
15. Shanks KG, Dahn T, Behonick G, Terrell A. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry. J Anal Toxicol 2012; 36: 360-371.